Switch theme
Sign up to access all valuation multiples
UK-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.
1993
769
LTM Revenue $267M
LTM EBITDA $59.6M
$671M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Advanced Medical Solutions Group has a last 12-month revenue (LTM) of $267M and a last 12-month EBITDA of $59.6M.
In the most recent fiscal year, Advanced Medical Solutions Group achieved revenue of $169M and an EBITDA of $43.4M.
Advanced Medical Solutions Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Advanced Medical Solutions Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $267M | XXX | $169M | XXX | XXX | XXX |
| Gross Profit | $140M | XXX | $94.2M | XXX | XXX | XXX |
| Gross Margin | 53% | XXX | 56% | XXX | XXX | XXX |
| EBITDA | $59.6M | XXX | $43.4M | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 26% | XXX | XXX | XXX |
| EBIT | $44.8M | XXX | $25.4M | XXX | XXX | XXX |
| EBIT Margin | 17% | XXX | 15% | XXX | XXX | XXX |
| Net Profit | $31.4M | XXX | $21.3M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 13% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Advanced Medical Solutions Group's stock price is GBP 2 (or $3).
Advanced Medical Solutions Group has current market cap of GBP 430M (or $577M), and EV of GBP 499M (or $671M).
See Advanced Medical Solutions Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $671M | $577M | XXX | XXX | XXX | XXX | $0.15 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Advanced Medical Solutions Group has market cap of $577M and EV of $671M.
Advanced Medical Solutions Group's trades at 4.0x EV/Revenue multiple, and 15.4x EV/EBITDA.
Equity research analysts estimate Advanced Medical Solutions Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Advanced Medical Solutions Group has a P/E ratio of 18.4x.
See valuation multiples for Advanced Medical Solutions Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $577M | XXX | $577M | XXX | XXX | XXX |
| EV (current) | $671M | XXX | $671M | XXX | XXX | XXX |
| EV/Revenue | 2.5x | XXX | 4.0x | XXX | XXX | XXX |
| EV/EBITDA | 11.2x | XXX | 15.4x | XXX | XXX | XXX |
| EV/EBIT | 15.0x | XXX | 26.4x | XXX | XXX | XXX |
| EV/Gross Profit | 4.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 18.4x | XXX | 27.1x | XXX | XXX | XXX |
| EV/FCF | 79.4x | XXX | 200.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAdvanced Medical Solutions Group's last 12 month revenue growth is 18%
Advanced Medical Solutions Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Advanced Medical Solutions Group's rule of 40 is 47% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Advanced Medical Solutions Group's rule of X is 68% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Advanced Medical Solutions Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 18% | XXX | 39% | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | 18% | XXX | 20% | XXX | XXX | XXX |
| Rule of 40 | 47% | XXX | 44% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 68% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 41% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Advanced Medical Solutions Group acquired XXX companies to date.
Last acquisition by Advanced Medical Solutions Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Advanced Medical Solutions Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Advanced Medical Solutions Group founded? | Advanced Medical Solutions Group was founded in 1993. |
| Where is Advanced Medical Solutions Group headquartered? | Advanced Medical Solutions Group is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Advanced Medical Solutions Group have? | As of today, Advanced Medical Solutions Group has 769 employees. |
| Who is the CEO of Advanced Medical Solutions Group? | Advanced Medical Solutions Group's CEO is Mr. Christopher Andrew Meredith. |
| Is Advanced Medical Solutions Group publicy listed? | Yes, Advanced Medical Solutions Group is a public company listed on LON. |
| What is the stock symbol of Advanced Medical Solutions Group? | Advanced Medical Solutions Group trades under AMS ticker. |
| When did Advanced Medical Solutions Group go public? | Advanced Medical Solutions Group went public in 2002. |
| Who are competitors of Advanced Medical Solutions Group? | Similar companies to Advanced Medical Solutions Group include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Advanced Medical Solutions Group? | Advanced Medical Solutions Group's current market cap is $577M |
| What is the current revenue of Advanced Medical Solutions Group? | Advanced Medical Solutions Group's last 12 months revenue is $267M. |
| What is the current revenue growth of Advanced Medical Solutions Group? | Advanced Medical Solutions Group revenue growth (NTM/LTM) is 18%. |
| What is the current EV/Revenue multiple of Advanced Medical Solutions Group? | Current revenue multiple of Advanced Medical Solutions Group is 2.5x. |
| Is Advanced Medical Solutions Group profitable? | Yes, Advanced Medical Solutions Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Advanced Medical Solutions Group? | Advanced Medical Solutions Group's last 12 months EBITDA is $59.6M. |
| What is Advanced Medical Solutions Group's EBITDA margin? | Advanced Medical Solutions Group's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Advanced Medical Solutions Group? | Current EBITDA multiple of Advanced Medical Solutions Group is 11.2x. |
| What is the current FCF of Advanced Medical Solutions Group? | Advanced Medical Solutions Group's last 12 months FCF is $8.4M. |
| What is Advanced Medical Solutions Group's FCF margin? | Advanced Medical Solutions Group's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Advanced Medical Solutions Group? | Current FCF multiple of Advanced Medical Solutions Group is 79.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
